跳至主要内容
临床试验/NCT00323531
NCT00323531已完成2 期

Thoracoscopy Versus Fibrinolysis in Children With Empyema

Children's Mercy Hospital Kansas City2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2006年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
36
试验地点
2
主要终点
Length of hospitalization after intervention

研究概览

简要总结

The null hypothesis is that patients receiving either thoracoscopy or fibrinolysis for empyema recover in the same amount of time. Therefore, we will test this by randomizing the next 40 patients who consent to the study to one treatment or the other.

详细描述

This will be a single institution, prospective, randomized clinical trial involving patients who are found to have at least a single septation within a pleural effusion as diagnosed by ultrasound or computed tomography. Additionally, patients with a pleural effusion wherein a pleural tap reveals pus as defined by many (> 10,000/mm3 ) white blood cells or positive cultures will be considered. This is intended to be a definitive study.

Power calculations based on the known 4.8 post intervention hospital days after VATS and the estimated 7 post intervention days after fibrinolysis with α = 0.05 and power of 0.8 show the need for 18 patients in each arm. We will intend to recruit 40. This sample size was constructed in consultation with Dr. Steve Simon, and the range of hospital stay in our retrospective experience was utilized. Therefore, this number should represent an adequate power in spite of the known varied level of illness.

One group will undergo thoracoscopy to clean the pleural space and leave a chest tube postoperatively to drainage. The other group will undergo chest tube placement with subsequent infusion of fibrinolytics to dissolve the thick purulent material allowing drainage.

Both groups will have the same antibiotic regimen with the same management algorithm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients less than 18 years of age requiring an intervention for empyema by one of the following:
  • Septation or loculation seen on ultrasound or computed tomography
  • Many white blood cells, bacteria present, or thick viscid purulence identified on pleural tap

排除标准

  • Immunodeficiency process
  • Secondary diagnosis or condition that will keep them in the hospital beyond the empyema
  • Existing contraindications to VATS or chest tube.

结局指标

主要结局

Length of hospitalization after intervention

时间窗: 1 month

次要结局

  • Days where a maximum temperature was equal to or above 38 degrees C, days of tube drainage, doses of analgesia and days of oxygen requirement, hospital days after intervention, hospital charges after intervention and procedure charges(1 month)

研究者

发起方
Children's Mercy Hospital Kansas City
申办方类型
Other

研究点 (2)

Loading locations...

相似试验